State of Wyoming’s Beam Therapeutics BEAM Stock Holding History

State of Wyoming’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,049	Closed	-$224K	–	1656
2024 Q4	$224K	Buy	9,049 +4,936	+120%	+$126K	0.03%	751
2024 Q3	$101K	Sell	4,113 -2,080	-34%	-$53.7K	0.01%	1129
2024 Q2	$145K	Buy	+6,193	New	+$152K	0.02%	804
2022 Q2	–	Sell	-729	Closed	-$42K	–	1875
2022 Q1	$42K	Buy	729 +251	+53%	+$16.5K	0.02%	1147
2021 Q4	$38K	Buy	478 +77	+19%	+$6.59K	0.02%	1226
2021 Q3	$35K	Sell	401 -374	-48%	-$37.6K	0.02%	849
2021 Q2	$100K	Buy	775 +318	+70%	+$25.3K	0.06%	455
2021 Q1	$37K	Buy	+457	New	+$43.5K	0.06%	257

Other funds holding BEAM

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State of Wyoming's BEAM Position: Q1 2025 in Review

State of Wyoming sold out of Beam Therapeutics (BEAM) in Q1 2025, closing a stake of 9,049 shares — an estimated $224K sold.

State of Wyoming first reported a position in BEAM in Q1 2021 and held it in 8 quarters. The position peaked at $224K in Q4 2024. 238 funds tracked by Wall St. Rank hold BEAM as of Q1 2025.

State of Wyoming reported no remaining Beam Therapeutics position as of Q1 2025 after selling out during the quarter.
State of Wyoming sold 9,049 Beam Therapeutics shares in Q1 2025, an estimated $224K.
State of Wyoming first reported a position in Beam Therapeutics in Q1 2021 and held it in 8 quarters.
State of Wyoming's Beam Therapeutics position peaked at $224K in Q4 2024.
238 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2025.

Based on State of Wyoming's 13F filing for Q1 2025, filed 14 May 2025.